skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice

Journal Article · · International Journal of Radiation Oncology, Biology and Physics; (United States)

In a clinical trial in which a 2-nitroimidazole radiosensitizer was administered repeatedly, the dose-limiting toxicity was found to be peripheral neuropathy. In the present study, the in vivo radiosensitizing activity of KU-2285 in combination with radiation dose fractionation, and the pharmacokinetics of cumulative dosing of KU-2285 in the peripheral nerves were examined. The ability of three nitroimidazoles, misonidazole (MISO), etanidazole (SR-2508) and KU-2285, to sensitize SCCVII tumors to radiation treatment has been compared for drug doses in the range 0-200 mg/kg. Single radiation doses or two different fractionation schedules (6 Gy/fractions [times] three fractions/48 h or 5 Gy/fractions [times] five fractions/48 h) were used; the tumor cell survival was determined using an in vivo/in vitro colony assay. The pharmacokinetics in the sciatic nerves were undertaken, when KU-2285 or etanidazole were injected at a dose of 200 mg/kg intravenously one, two, three, or four times at 2-h intervals. At less than 100 mg/kg, KU-2285 sensitized SCCVII tumors more than MISO and SR-2508 by fractionated irradiation. Evaluation of pharmacokinetics in the peripheral nerves showed that the apparent biological half-life of SR-2508 increased with the increases in the number of administrations, whereas that of KU-2285 became shorter. Since most clinical radiotherapy is given in small multiple fractions, KU-2285 appears to be a hypoxic cell radiosensitizer that could be useful in such regimens, and that poses no risk of chronic peripheral neurotoxicity. 12 refs., 5 figs., 1 tab.

OSTI ID:
6946408
Journal Information:
International Journal of Radiation Oncology, Biology and Physics; (United States), Vol. 29:3; ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses
Journal Article · Wed Dec 01 00:00:00 EST 1993 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:6946408

Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses
Journal Article · Wed Jun 15 00:00:00 EDT 1994 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:6946408

KIN-804 vs. KU-2285 as a radiosensitizer for clinical use
Journal Article · Wed Jun 15 00:00:00 EDT 1994 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:6946408